BPC-157 For Knee Pain: Early Reported Outcomes A report on intra-articular BPC-157 for knee pain described high rates of improvement: ~92% with BPC-157 alone, ~75% when combined with thymosin beta-4, and overall pain relief reported in 87.5% of patients
However, unlike these peptides, PRP has been studied extensively in humans and has a strong safety profile overall, although its not risk-free
Run together: AOD 9604 burns down existing fat stores while MOTS-c improves how your body processes fuel going forward, burning fat, not just storing it
It's become a popular ingredient in pre-workout supplements due to its ability to boost nitric oxide levels [1]
The author and publisher accept no liability for misuse of the information contained
Proper dosing protocolstypically 250-500 mcg daily via subcutaneous injection in a fasted stateprovide the foundation for optimal results while minimizing side effects